Emory University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Emory University sits in the top decile of US sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count).
Emory University: 1,208 sponsored US clinical trials, 208 recruiting.
Emory University sponsors 1,208 registered US clinical trials on ClinicalTrials.gov, 208 of them currently recruiting, and 767 completed. 170 of these trials are in Phase 3-4 (later-stage) and 344 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 12 trials.
Top-decile sponsor footprint
Emory University ranks in the top decile of sponsors by registered trial count (#24 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
767 of 926 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,208 total, page 3 of 25
F18-MHF: Orthopedic Implants-Associated Infection Detection
NCT05889286
Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
NCT06328686
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
NCT05741164
Pectoralis Minor Release Versus Non-release in RSA
NCT06292169
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
NCT06423326
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
NCT06595160
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
NCT06492070
Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners
NCT06250725
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
NCT06495125
Inspiring Seniors Towards Exercise Promotion to Protect Cognition
NCT06496425
Behavioral Intervention to Reduce Stress Among Black Gender Minority Women
NCT05436106
Further MT for Antibiotic-Resistant Bacterial Colonization in Inpatients
NCT05835206
Anti-Inflammatory Challenge in Schizophrenia
NCT05823532
A Pilot and Feasibility Study to Evaluate High vs Low Glycemic Index Mixed Meal Tolerance Test in Adolescents and Young Adults With Cystic Fibrosis
NCT06350149
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
NCT06257576
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
NCT05834478
AB Gait Estim Neurophysiology
NCT06430164
Trial of Community-based Patient Navigation
NCT05588245
Non-Invasive Diagnostic Tests for MASLD in Pediatric Population
NCT06218589
Arginine Replacement Therapy in COVID-19
NCT05855330
Health Behavior Intervention for Adults With Type 1 Diabetes
NCT05823142
Inflammation and Depression in People With HIV
NCT05849038
Dopaminergic Therapy for Anhedonia - 2
NCT06075771
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer
NCT05998135
Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
NCT05400603
Bone Marrow and Peripheral Blood Immune Responses Study
NCT05616546
Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology
NCT05756569
Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
NCT05711056
Effect of Personalized Pain Coaches After Orthopaedic Surgery for Patients With Sports Medicine Injuries
NCT05821699
Virtual Rehabilitation in HCT
NCT05943964
Perilunate Management
NCT05824078
FEED-Cystic Fibrosis (FEED-CF)
NCT05766774
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
NCT05877859
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
NCT05065840
Ondansetron As a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial
NCT05378113
Caregiving While Black
NCT05772689
A Web-Based Dyadic Intervention for Colorectal Cancer
NCT05663203
Low Dose Naltrexone for Pain in Patients With HIV
NCT05537935
Spatial-Motor Stroke-Rehab Study
NCT06053320
Durability of Vaccine Responses
NCT05801978
DELTA (Detecting and Predicting Atrial Fibrillation in Post-Stroke Patients)
NCT05795842
A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy
NCT05488145
Symptom Care at Home-Heart Failure
NCT04347759
Screening for Autism in 9-Month-Olds by Measuring Social Visual Engagement
NCT05916430
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
NCT05292339
Mechanisms of Behavioral Activation (BA)
NCT05548244
Perioperative Steroid Dosing on the APR in AIS
NCT05561725
Disrupting Fear-based Memory Consolidation
NCT05560113
Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD
NCT05928936
Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
NCT05327699
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 154 |
| Phase 2 | 190 |
| Phase 3 | 36 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Emory University pipeline
208 recruiting of 1,208 indexed (17% open); 767 completed (63%).
Phase mix: 170 late (III/IV) vs 344 early (I/II) (early-phase heavy).
Top condition: Depression (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Emory University: open-pipeline peers nationwide
Peers matched on 1,208 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Emory University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,208 trials (± recruiting share)
- Northwestern University · 1,209 trials · 15% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
Sponsors near 17% open enrollment (± trial volume)
- Baylor Research Institute · 17% recruiting · 180 trials
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) · 17% recruiting · 93 trials
- Hunter College of City University of New York · 17% recruiting · 29 trials
- Ochsner Health System · 17% recruiting · 29 trials
Related
What to do with this Emory University page
1,208 registered trials is a research-attention snapshot, not an endorsement of Emory University or any single study.
- 208 of Emory University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition Emory University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Emory University pipeline card: 1,208 registered trials from official public datasets.Report a data error.